共 50 条
Cannabidiol as potential treatment in refractory pediatric epilepsy
被引:18
|作者:
Paolino, Maria Chiara
[1
]
Ferretti, Alessandro
[1
]
Papetti, Laura
[2
]
Villa, Maria Pia
[1
]
Parisi, Pasquale
[1
]
机构:
[1] Univ Roma La Sapienza, Headache Paediat Ctr, Fac Med & Psychol,Chair Pediat,St Andrea Hosp, Paediat Sleep Disorders,Child Neurol,NESMOS Dept, Rome, Italy
[2] Univ Roma La Sapienza, Dept Pediat, Child Neurol Div, Piazzale Aldo Moro 5, I-00185 Rome, Italy
关键词:
Cannabis;
cannabidiol;
CBD;
epilepsy;
refractory epilepsy in children;
MITOCHONDRIAL-FUNCTION;
PLANT CANNABINOIDS;
MEDICAL MARIJUANA;
SEIZURES;
EXTRACTS;
PHARMACOLOGY;
SYMPTOMS;
EFFICACY;
DRUGS;
D O I:
10.1586/14737175.2016.1121098
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
In recent years there has been great scientific and public interest focused on the therapeutic potential of compounds derived from cannabis for the treatment of refractory epilepsy in children. From in vitro and in vivo studies on animal models, cannabidiol (CBD) appears to be a promising anticonvulsant drug with a favorable side-effect profile. In humans, CBD efficacy and safety is not supported by well-designed trials and its use has been described by anecdotal reports. It will be necessary to investigate CBD safety, pharmacokinetics and interaction with other anti-epileptic drugs (AEDs) alongside performing double-blinded placebo-controlled trials in order to obtain conclusive data on its efficacy and safety in children.
引用
收藏
页码:17 / 21
页数:5
相关论文